251 related articles for article (PubMed ID: 22593015)
21. SCL-GFP transgenic zebrafish: in vivo imaging of blood and endothelial development and identification of the initial site of definitive hematopoiesis.
Zhang XY; Rodaway AR
Dev Biol; 2007 Jul; 307(2):179-94. PubMed ID: 17559829
[TBL] [Abstract][Full Text] [Related]
22. The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.
Göttgens B; Broccardo C; Sanchez MJ; Deveaux S; Murphy G; Göthert JR; Kotsopoulou E; Kinston S; Delaney L; Piltz S; Barton LM; Knezevic K; Erber WN; Begley CG; Frampton J; Green AR
Mol Cell Biol; 2004 Mar; 24(5):1870-83. PubMed ID: 14966269
[TBL] [Abstract][Full Text] [Related]
23. Transcription factor SCL/TAL1 mediates the phosphorylation of MEK/ERK pathway in umbilical cord blood CD34⁺ stem cells during hematopoietic differentiation.
Zhou RQ; Wu JH; Gong YP; Guo Y; Xing HY
Blood Cells Mol Dis; 2014; 53(1-2):39-46. PubMed ID: 24405580
[TBL] [Abstract][Full Text] [Related]
24. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis.
Drake CJ; Brandt SJ; Trusk TC; Little CD
Dev Biol; 1997 Dec; 192(1):17-30. PubMed ID: 9405094
[TBL] [Abstract][Full Text] [Related]
25. Reconstitution of mice with bone marrow cells expressing the SCL gene is insufficient to cause leukemia.
Elwood NJ; Begley CG
Cell Growth Differ; 1995 Jan; 6(1):19-25. PubMed ID: 7718483
[TBL] [Abstract][Full Text] [Related]
26. Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; MacLeod RA
Leuk Res; 2010 Apr; 34(4):521-8. PubMed ID: 19608273
[TBL] [Abstract][Full Text] [Related]
27. In vivo fate mapping with SCL regulatory elements identifies progenitors for primitive and definitive hematopoiesis in mice.
Bockamp E; Antunes C; Liebner S; Schmitt S; Cabezas-Wallscheid N; Heck R; Ohnngemach S; Oesch-Bartlomowicz B; Rickert C; Sanchez MJ; Hengstler J; Kaina B; Wilson A; Trumpp A; Eshkind L
Mech Dev; 2009 Oct; 126(10):863-72. PubMed ID: 19631738
[TBL] [Abstract][Full Text] [Related]
28. Chromatin immunoselection defines a TAL-1 target gene.
Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
[TBL] [Abstract][Full Text] [Related]
29. Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene.
Robb L; Lyons I; Li R; Hartley L; Köntgen F; Harvey RP; Metcalf D; Begley CG
Proc Natl Acad Sci U S A; 1995 Jul; 92(15):7075-9. PubMed ID: 7624372
[TBL] [Abstract][Full Text] [Related]
30. SCL: from the origin of hematopoiesis to stem cells and leukemia.
Lécuyer E; Hoang T
Exp Hematol; 2004 Jan; 32(1):11-24. PubMed ID: 14725896
[TBL] [Abstract][Full Text] [Related]
31. Opposing effects of the basic helix-loop-helix transcription factor SCL on erythroid and monocytic differentiation.
Hoang T; Paradis E; Brady G; Billia F; Nakahara K; Iscove NN; Kirsch IR
Blood; 1996 Jan; 87(1):102-11. PubMed ID: 8547631
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells.
Elefanty AG; Robb L; Birner R; Begley CG
Blood; 1997 Aug; 90(4):1435-47. PubMed ID: 9269761
[TBL] [Abstract][Full Text] [Related]
33. Hemogenic endothelium specification and hematopoietic stem cell maintenance employ distinct Scl isoforms.
Zhen F; Lan Y; Yan B; Zhang W; Wen Z
Development; 2013 Oct; 140(19):3977-85. PubMed ID: 24046317
[TBL] [Abstract][Full Text] [Related]
34. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
35. Shared roles for
Chiu SK; Orive SL; Moon MJ; Saw J; Ellis S; Kile BT; Huang Y; Chacon D; Pimanda JE; Beck D; Hamilton JR; Tremblay CS; Curtis DJ
Blood; 2019 Sep; 134(10):826-835. PubMed ID: 31300405
[TBL] [Abstract][Full Text] [Related]
36. The SCL 3' enhancer responds to Hedgehog signaling during hemangioblast specification.
Hochman E; Kinston S; Harmelin A; Göttgens B; Izraeli S
Exp Hematol; 2006 Dec; 34(12):1643-50. PubMed ID: 17157160
[TBL] [Abstract][Full Text] [Related]
37. The role of the stem cell leukemia (SCL) gene in hematopoietic and endothelial lineage specification.
Bloor AJ; Sánchez MJ; Green AR; Göttgens B
J Hematother Stem Cell Res; 2002 Apr; 11(2):195-206. PubMed ID: 11983093
[TBL] [Abstract][Full Text] [Related]
38. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
[TBL] [Abstract][Full Text] [Related]
39. SCL/TAL1: a multifaceted regulator from blood development to disease.
Porcher C; Chagraoui H; Kristiansen MS
Blood; 2017 Apr; 129(15):2051-2060. PubMed ID: 28179281
[TBL] [Abstract][Full Text] [Related]
40. Kit and Scl regulation of hematopoietic stem cells.
Rojas-Sutterlin S; Lecuyer E; Hoang T
Curr Opin Hematol; 2014 Jul; 21(4):256-64. PubMed ID: 24857885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
